Ezekowitz Alan — SEC insider filings

SEC reporting owner CIK 1780209. 19 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2020-12-07 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Septerna, Inc. (SEPN)Director54 legs · 100,000 sh · $608,2047 legs · 81,820 sh · $3,934,3632
Fulcrum Therapeutics, Inc. (FULC)Director8—1 leg · 18,000 sh · $65,6148
Organon & Co. (OGN)Director6——6

Insider filings — Ezekowitz Alan

FiledFormIssuerReported transactionsSource
2026-11-134Septerna, Inc. (SEPN)Sale (S): 6,939 @ $46.01 · Sale (S): 13,201 @ $47.01 · Sale (S): 22,865 @ $47.78 · Sale (S): 31,572 @ $48.70 · Sale (S): 4,175 @ $49.65 · Sale (S): 2,013 @ $50.90 · +1 moreEDGAR
2026-07-024Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2026-06-304Fulcrum Therapeutics, Inc. (FULC)Sale (S): 18,000 @ $3.65EDGAR
2026-06-304Septerna, Inc. (SEPN)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2026-06-154Organon & Co. (OGN)Grant/award (A): 17,857.14 (derivative) @ $13.44EDGAR
2025-06-304Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 36,000 (derivative) @ $0EDGAR
2025-06-204Septerna, Inc. (SEPN)Grant/award (A): 16,623 (derivative) @ $0EDGAR
2025-06-164Organon & Co. (OGN)Grant/award (A): 23,904.38 (derivative) @ $10.04EDGAR
2025-03-104Septerna, Inc. (SEPN)Purchase (P): 13,319 @ $6.93EDGAR
2025-03-064Septerna, Inc. (SEPN)Purchase (P): 7,491 @ $6.35 · Purchase (P): 37,835 @ $5.82 · Purchase (P): 41,355 @ $6EDGAR
2024-06-184Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-06-114Organon & Co. (OGN)Grant/award (A): 9,638.55 (derivative) @ $20.75EDGAR
2023-06-294Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-06-134Organon & Co. (OGN)Grant/award (A): 10,086 (derivative) @ $19.83EDGAR
2022-06-294Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 19,000 (derivative) @ $0 · Other (J): 500 (derivative) @ $0EDGAR
2022-06-144Organon & Co. (OGN)Grant/award (A): 5,640 (derivative) @ $35.46EDGAR
2021-06-114Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-084Organon & Co. (OGN)Grant/award (A): 8,772 (derivative) @ $36.05EDGAR
2020-12-074Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 15,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780209 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs